Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Carbon fiber scaffolds in the surgical treatment of cartilage lesions.
Annals of transplantation·2000
[Contemporary views on treatment of cruciate ligament injuries].
Polimery w medycynie·1993
[Orthopedics in the Bible].
Chirurgia narzadow ruchu i ortopedia polska·1993
[Clinical evaluation of the usefulness of knee arthroscopy].
Chirurgia narzadow ruchu i ortopedia polska·1990
[Tuberculosis of the lymph nodes with esophageal-cutaneous fistula in a patient with AIDS].
Polski tygodnik lekarski (Warsaw, Poland : 1960)·1996
[Multiorgan changes in AIDS in a reported case].
Polski tygodnik lekarski (Warsaw, Poland : 1960)·1996
[Efficacy of cimetidine in treatment of Herpes zoster in the first 5 days from the moment of disease manifestation].
Polski tygodnik lekarski (Warsaw, Poland : 1960)·1996
[Antibody avidity in diagnosis of toxoplasmosis].
Polski tygodnik lekarski (Warsaw, Poland : 1960)·1996
[The effect of discontinuing intravenous opiate injections and methadone treatment on the status of the immune system in narcotic abusers with HIV].
Polski tygodnik lekarski (Warsaw, Poland : 1960)·1996
[Use of human anti-Pseudomonas immunoglobulins in treatment of children with burns].
Polski tygodnik lekarski (Warsaw, Poland : 1960)·1996
Time to Treatment Failure as a Recorded Treatment-Process Measure in C-CAT. Reply to Comment on "Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462".
Current oncology (Toronto, Ont.)·2026
Does Time to Treatment Failure Measure the Same Clinical Process Across Oncology Facilities? Comment on Kajiura et al. Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462.
Current oncology (Toronto, Ont.)·2026
[177Lu]Lu-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer: Evidence from PSMAddition and Considerations for Treatment Sequencing.
Current oncology (Toronto, Ont.)·2026
A New Era of Treatment Sequencing in Platinum-Resistant Ovarian Cancer: Integrating Immunotherapy, Antibody-Drug Conjugates, and Targeted Therapies.
Current oncology (Toronto, Ont.)·2026